GI
RARE icon

GAMMA Investing’s Ultragenyx Pharmaceutical RARE Stock Holding History

GAMMA Investing’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.1K Buy
1,919
+1,150
+150% +$28.6K ﹤0.01% 2130
2026
Q1 		$16.1K Buy
769
+184
+31% +$4.14K ﹤0.01% 2834
2025
Q4 		$13.5K Buy
585
+389
+198% +$12.8K ﹤0.01% 2831
2025
Q3 		$5.9K Sell
196
-411
-68% -$12.3K ﹤0.01% 3105
2025
Q2 		$22.1K Sell
607
-140
-19% -$5.05K ﹤0.01% 2400
2025
Q1 		$27K Buy
747
+323
+76% +$13.4K ﹤0.01% 2210
2024
Q4 		$17.8K Buy
424
+29
+7% +$1.44K ﹤0.01% 2323
2024
Q3 		$21.9K Buy
395
+267
+209% +$13.6K ﹤0.01% 2051
2024
Q2 		$5.26K Sell
128
-876
-87% -$37.4K ﹤0.01% 2556
2024
Q1 		$46.9K Buy
1,004
+865
+622% +$40.8K 0.01% 1087
2023
Q4 		$6.13K Buy
+139
New +$5.39K ﹤0.01% 2143

Other funds holding RARE

AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

GAMMA Investing's RARE Position: Q2 2026 in Review

GAMMA Investing increased its Ultragenyx Pharmaceutical (RARE) stake by 150% in Q2 2026, buying an estimated $28.6K and bringing the position to 1,919 shares worth $64.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2130.

GAMMA Investing first reported a position in RARE in Q4 2023 and has held it in 11 quarters since. 36 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • GAMMA Investing held 1,919 shares of Ultragenyx Pharmaceutical worth $64.1K as of Q2 2026.
  • GAMMA Investing bought 1,150 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $28.6K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2130 holding.
  • GAMMA Investing first reported a position in Ultragenyx Pharmaceutical in Q4 2023 and has held it in 11 quarters since.
  • 36 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.